Kristen McCullough

1.7k total citations
53 papers, 805 citations indexed

About

Kristen McCullough is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Kristen McCullough has authored 53 papers receiving a total of 805 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hematology, 19 papers in Genetics and 11 papers in Molecular Biology. Recurrent topics in Kristen McCullough's work include Acute Myeloid Leukemia Research (25 papers), Chronic Myeloid Leukemia Treatments (11 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers). Kristen McCullough is often cited by papers focused on Acute Myeloid Leukemia Research (25 papers), Chronic Myeloid Leukemia Treatments (11 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers). Kristen McCullough collaborates with scholars based in United States, United Arab Emirates and Saudi Arabia. Kristen McCullough's co-authors include Mrinal M. Patnaik, Julie L. Cunningham, Wayne T. Nicholson, Christine M. Formea, Jason N. Barreto, Narith N. Ou, Joanna L. Stollings, Judith A. Smith, Mark R. Litzow and William J. Hogan and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.

In The Last Decade

Kristen McCullough

49 papers receiving 787 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kristen McCullough United States 16 300 204 181 178 160 53 805
José Luís Poveda Spain 18 160 0.5× 78 0.4× 181 1.0× 68 0.4× 180 1.1× 90 922
MV Relling United States 12 363 1.2× 253 1.2× 329 1.8× 112 0.6× 725 4.5× 14 1.5k
Nancy Kornegay United States 8 93 0.3× 73 0.4× 115 0.6× 40 0.2× 346 2.2× 12 648
Geoff D.E. Cuvelier Canada 13 231 0.8× 24 0.1× 51 0.3× 44 0.2× 174 1.1× 49 651
Jean‐Marie Leclerc Canada 18 139 0.5× 19 0.1× 167 0.9× 75 0.4× 314 2.0× 57 1.1k
Larry W. Buie United States 14 75 0.3× 27 0.1× 91 0.5× 52 0.3× 89 0.6× 38 535
Roberto Rivera‐Luna Mexico 16 141 0.5× 12 0.1× 129 0.7× 96 0.5× 280 1.8× 67 808
Jessie Githanga Kenya 13 27 0.1× 114 0.6× 278 1.5× 53 0.3× 271 1.7× 27 890
Mohammadreza Bordbar Iran 13 226 0.8× 12 0.1× 73 0.4× 172 1.0× 95 0.6× 93 593
Justin Arnall United States 12 113 0.4× 39 0.2× 64 0.4× 53 0.3× 38 0.2× 46 333

Countries citing papers authored by Kristen McCullough

Since Specialization
Citations

This map shows the geographic impact of Kristen McCullough's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristen McCullough with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristen McCullough more than expected).

Fields of papers citing papers by Kristen McCullough

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristen McCullough. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristen McCullough. The network helps show where Kristen McCullough may publish in the future.

Co-authorship network of co-authors of Kristen McCullough

This figure shows the co-authorship network connecting the top 25 collaborators of Kristen McCullough. A scholar is included among the top collaborators of Kristen McCullough based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristen McCullough. Kristen McCullough is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johnson, Isla McKerrow, Sunny Chen, Kristen McCullough, et al.. (2024). Cardiac events in newly diagnosed acute myeloid leukaemia during treatment with venetoclax + hypomethylating agents. British Journal of Haematology. 204(4). 1232–1237. 5 indexed citations
2.
Baranwal, Anmol, Mark E. Gurney, Aref Al‐Kali, et al.. (2024). The impact of cytotoxic therapy on the risk of progression and death in clonal cytopenia(s) of undetermined significance. Blood Advances. 8(12). 3130–3139. 5 indexed citations
3.
Xie, Zhuoer, Jenna Fernandez, Terra L. Lasho, et al.. (2024). High-dose IV ascorbic acid therapy for patients with CCUS with TET2 mutations. Blood. 144(23). 2456–2461. 6 indexed citations
4.
McCullough, Kristen, Zhuoer Xie, Terra L. Lasho, et al.. (2024). Phase II Trial Assessing Safety and Preliminary Efficacy of High-Dose Intravenous Ascorbic Acid and Decitabine in TET2-Mutant Chronic Myelomonocytic Leukemia. Blood. 144(Supplement 1). 6699–6699. 2 indexed citations
5.
Galardy, Paul J., et al.. (2023). Attempted desensitization to calaspargase pegol: a familiar approach to a new problem. Leukemia & lymphoma. 65(3). 407–409. 2 indexed citations
6.
McCullough, Kristen, Aref Al‐Kali, Hassan B. Alkhateeb, et al.. (2023). Venetoclax + Cladribine + Low-Dose Cytarabine in Acute Myeloid Leukemia Relapsed or Refractory to Venetoclax + Hypomethylating Agent. Blood. 142(Supplement 1). 2853–2853. 1 indexed citations
7.
Shah, Mithun Vinod, Abhishek A. Mangaonkar, Kebede H. Begna, et al.. (2022). Therapy-related clonal cytopenia as a precursor to therapy-related myeloid neoplasms. Blood Cancer Journal. 12(7). 106–106. 10 indexed citations
8.
Johnson, Isla McKerrow, Evandro D. Bezerra, Kristen McCullough, et al.. (2022). Cardiac events in patients with acute myeloid leukemia treated with venetoclax combined with hypomethylating agents. Blood Advances. 6(17). 5227–5231. 16 indexed citations
9.
Gangat, Naseema, Kristen McCullough, Kebede H. Begna, et al.. (2022). Predictors of Response to Venetoclax Plus Hypomethylating Agent Therapy and Survival in Blast-Phase Myeloproliferative Neoplasm. Blood. 140(Supplement 1). 9675–9676. 1 indexed citations
10.
Dalvin, Lauren A., Timothy W. Olsen, Sophie J. Bakri, et al.. (2022). Busulfan Treatment for Myeloproliferative Disease may Reduce Injection Burden in Vascular Endothelial Growth Factor-Driven Retinopathy. American Journal of Ophthalmology Case Reports. 26. 101554–101554. 2 indexed citations
11.
Gangat, Naseema, Isla McKerrow Johnson, Kristen McCullough, et al.. (2022). Molecular predictors of response to venetoclax plus hypomethylating agent in treatment-naïve acute myeloid leukemia. Haematologica. 107(10). 2501–2505. 25 indexed citations
12.
Johnson, Isla McKerrow, Evandro D. Bezerra, Kristen McCullough, et al.. (2021). Cardiac Events in Patients with Acute Myeloid Leukemia Treated with Venetoclax in Combination with Hypomethylating Agents. Blood. 138(Supplement 1). 219–219.
13.
Herrmann, Joerg, Kristen McCullough, & Thomas M. Habermann. (2021). How I treat cardiovascular complications in patients with lymphoid malignancies. Blood. 139(10). 1501–1516. 3 indexed citations
14.
Parikh, Sameer A., Sara J. Achenbach, Timothy G. Call, et al.. (2020). The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice. Cancer Medicine. 9(10). 3390–3399. 39 indexed citations
15.
Morsia, Erika, Kristen McCullough, Joselle Cook, et al.. (2020). Venetoclax and hypomethylating agents in acute myeloid leukemia: Mayo Clinic series on 86 patients. American Journal of Hematology. 95(12). 1511–1521. 89 indexed citations
16.
Habermann, Thomas M., John J. Schmitz, Jason R. Young, et al.. (2018). An Analysis of a Multidisciplinary Lymphoma Virtual Tumor Board with Regional and International Participation. Blood. 132(Supplement 1). 2247–2247. 2 indexed citations
17.
McCullough, Kristen, William J. Hogan, Kebede H. Begna, et al.. (2017). Outcome of elderly patients after failure to hypomethylating agents given as frontline therapy for acute myeloid leukemia: Single institution experience*. American Journal of Hematology. 92(9). 866–871. 15 indexed citations
18.
Barreto, Jason N., Kristen McCullough, Ross Dierkhising, et al.. (2017). Safety and feasibility of lower antithrombin replacement targets in adult patients with hematological malignancies receiving asparaginase therapy. Leukemia & lymphoma. 58(11). 2588–2597. 11 indexed citations
19.
Formea, Christine M., Wayne T. Nicholson, Kristen McCullough, et al.. (2013). Development and Evaluation of a Pharmacogenomics Educational Program for Pharmacists. American Journal of Pharmaceutical Education. 77(1). 10–10. 67 indexed citations
20.
McCullough, Kristen, Christine M. Formea, Julie L. Cunningham, et al.. (2011). Assessment of the Pharmacogenomics Educational Needs of Pharmacists. American Journal of Pharmaceutical Education. 75(3). 51–51. 155 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026